Daniel Hurni

Director Strategy and Business Operations Bristol Myers Squibb

Conference Day One

9:45 AM CHARTING THE EVOLUTION OF CMO SELECTION CRITERIA & ITS IMPACT ON OUR ABILITY TO IDENTIFY & COLLABORATE WITH THE RIGHT PARTNERS

How are we to go about making the crucial decision about who we partner with? In this next panel discussion we ask how you can achieve the depth of knowledge required to select not only a reliable partner, but the right partner who meets a range of criteria.

Core focus areas to include:

  • Aligning Goals & Expectations Ensuring that your goals are aligned is essential. But how do you achieve this level of transparency early on? What are the deeper level questions that need answering?
  • Values & Culture: How can you discern whether a potential CMO is aligned with your goals and objectives and fully committed to delivering on what you need
  • What Your Product Needs: You need a partner who appreciates the specificity & uniqueness of your product – and can deliver it to a high standard. What does this synergy look like in practice?
  • Evolving Criteria: How is the hierarchy of selection criteria evolving and how can you identify those partners who have the agility and flexibility to respond?

4:30 PM THE BIG QUESTION: HOW IS RISING OPERATIONAL COMPLEXITY & UNCERTAINTY IMPACTING OUR LONG-TERM DECISION-MAKING IN PHARMA CONTRACT MANUFACTURING

How is rising operational complexity & uncertainty impacting our long-term decision-making in pharma contract manufacturing? In this concluding session, we ask how the macro-economic environment and geo-political situation are impacting not only our ability to achieve our goals but also our decisions and where and who to partner with.

Core focus areas to include:

  • The Future Outlook: How are we to incorporate geo-politics in our decision-making, weighing up the pros and cons of partnering with particular regions of the world?
  • Risk Mitigation Strategies: We explore what ‘cost-effective risk-mitigation’ means in-practice. How can you make the argument for investing more to offset risk?
  • The Evolution of Risk: Discover how evolving regulatory factors, such as environmental impact mitigation, are changing the way in which we need to define operational risk
  • Implications for Partner Localities: Is there now a greater emphasis on the locality of a potential partner due to operational complexity and uncertainty on a global scale?

Check out the incredible speaker line-up to see who will be joining Daniel.

Download The Latest Agenda